Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04482374

Puberty Suppression and Cardiometabolic Health

Effects of Puberty and Pubertal Suppression on Insulin Sensitivity, Metabolic Rate and Vascular Health

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
Male
Age
9 Years – 14 Years
Healthy volunteers

Summary

This observational study will evaluate the effect of puberty suppression on insulin sensitivity, metabolic rate and vascular health among transgender female youth at baseline and 6 months after initiation of a gondoatropin releasing hormone agonist compared to matched cisgender male controls.

Conditions

Timeline

Start date
2020-08-10
Primary completion
2026-07-31
Completion
2026-07-31
First posted
2020-07-22
Last updated
2025-06-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04482374. Inclusion in this directory is not an endorsement.

Puberty Suppression and Cardiometabolic Health (NCT04482374) · Clinical Trials Directory